Weight loss jabs can slash the risk of heart patients dying or being admitted to hospital by more than half, the largest study of its kind suggests. Researchers said millions more patients could soon ...

Share on Pinterest Weight loss drugs could help improve health outcomes in people with heart failure. The Good Brigade/Getty Images Researchers report that the weight loss drugs semaglutide and ...

Add Yahoo as a preferred source to see more of our stories on Google. Weight-loss jabs like Ozempic/Wegovy have been touted as miracle drugs revolutionizing how obesity is treated. Steffen Trumpf/dpa ...

Low doses of the injectable weight-loss medication semaglutide may improve symptoms of a hard-to-treat type of heart failure. This effect happened through direct action on the heart muscle and blood ...

Share on Pinterest Ozempic, the active ingredient of which is semaglutide, can also reduce the risk of heart disease, according to research. Steve Christo – Corbis/Corbis via Getty Images Preventing ...

Panelists discuss how GLP-1 receptor agonists show promising benefits for patients with HFpEF, particularly those with obesity-related disease, through significant weight loss and improved functional ...

Researchers report that the weight loss drugs semaglutide and tirzepatide can reduce the risk of hospitalization and death by 40% in people with a common type of heart failure. Experts say this large ...